✦ LIBER ✦

Revisiting prediction models in policing: Identifying high-risk offenders

✍ Scribed by Wesley G. Jennings

Book ID: 105642429
Publisher: Springer-Verlag
Year: 2006
Tongue: English
Weight: 910 KB
Volume: 31
Category: Article
ISSN: 1066-2316
DOI: 10.1007/bf02885683

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A measurement model of perinatal stresso

A measurement model of perinatal stressors: Identifying risk for postnatal emotional distress in mothers of high-risk infants

✍ Richart L. DeMier; Michael T. Hynan; Rebecca F. Hatfield; Michael W. Varner; How 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

A measurement model of perinatal stressors was first evaluated for reliability and then used to identify risk factors for postnatal emotional distress in high-risk mothers. In Study 1, six measures (gestational age of the baby, birthweight, length of the baby's hospitalization, a postnatal complicat

The absolute monocyte and lymphocyte pro

The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma

✍ Wilcox, R A; Ristow, K; Habermann, T M; Inwards, D J; Micallef, I N M; Johnston, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 477 KB

A statistical model predicting high hepa

A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis

✍ F. AZZAROLI; A. COLECCHI; F. LODATO; D. TRERÈ; M. L. BACCHI REGGIANI; D. FESTI; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Results of intensive chemotherapy in 998

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: : Predictive prognostic models for outcome

✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Eli 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract ## BACKGROUND Elderly patients (age ≥ 65 years) with acute myeloid leukemia (AML) generally have a poor prognosis. AML‐type therapy results are often derived from studies in younger patients and may not apply to elderly AML. Many investigators and oncologists advocate, at times, only s